USA - NASDAQ:DHC - US25525P1075 - REIT
The current stock price of DHC is 4.63 USD. In the past month the price increased by 13.76%. In the past year, price increased by 83.73%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| WELL | WELLTOWER INC | 133.67 | 129.63B | ||
| VTR | VENTAS INC | 150 | 35.45B | ||
| OHI | OMEGA HEALTHCARE INVESTORS | 23.64 | 12.97B | ||
| DOC | HEALTHPEAK PROPERTIES INC | 86.75 | 12.06B | ||
| ARE | ALEXANDRIA REAL ESTATE EQUIT | N/A | 9.04B | ||
| AHR | AMERICAN HEALTHCARE REIT INC | 105.04 | 8.15B | ||
| CTRE | CARETRUST REIT INC | 26.19 | 8.01B | ||
| HR | HEALTHCARE REALTY TRUST INC | N/A | 6.39B | ||
| SBRA | SABRA HEALTH CARE REIT INC | 25.9 | 4.47B | ||
| DHCNL | DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 | N/A | 4.29B | ||
| DHCNI | DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 | N/A | 4.10B | ||
| NHI | NATL HEALTH INVESTORS INC | 25.46 | 3.66B |
Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. The company is headquartered in Newton, Massachusetts and currently employs 0 full-time employees. The firm is focused on owning healthcare properties located throughout the United States. The company has an approximately $7.2 billion portfolio, which includes over 367 properties in 36 states and Washington, D.C., occupied by approximately 450 tenants, and totaling approximately 8.0 million square feet of life science and medical office properties and more than 27,000 senior living units. The firm's segments include Medical Office and Life Science Portfolio and SHOP. Its Medical Office and Life Science Portfolio segment primarily consists of medical office properties leased to medical providers and other medical-related businesses, as well as life science properties primarily leased to biotech laboratories and other similar tenants. Its SHOP segment consists of managed senior living communities that provide short-term and long-term residential living and, in some instances, care and other services for residents.
DIVERSIFIED HEALTHCARE TRUST
C/O The Rmr Group, Two Newton Pl., 255 Wash. St., Ste. 300
Newton MASSACHUSETTS 02458 US
CEO: Jennifer F. (Francis) Mintzer
Employees: 200
Phone: 16177968350
Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. The company is headquartered in Newton, Massachusetts and currently employs 0 full-time employees. The firm is focused on owning healthcare properties located throughout the United States. The company has an approximately $7.2 billion portfolio, which includes over 367 properties in 36 states and Washington, D.C., occupied by approximately 450 tenants, and totaling approximately 8.0 million square feet of life science and medical office properties and more than 27,000 senior living units. The firm's segments include Medical Office and Life Science Portfolio and SHOP. Its Medical Office and Life Science Portfolio segment primarily consists of medical office properties leased to medical providers and other medical-related businesses, as well as life science properties primarily leased to biotech laboratories and other similar tenants. Its SHOP segment consists of managed senior living communities that provide short-term and long-term residential living and, in some instances, care and other services for residents.
The current stock price of DHC is 4.63 USD. The price decreased by -2.94% in the last trading session.
DIVERSIFIED HEALTHCARE TRUST (DHC) has a dividend yield of 0.84%. The yearly dividend amount is currently 0.04.
DHC has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
10 analysts have analysed DHC and the average price target is 4.34 USD. This implies a price decrease of -6.37% is expected in the next year compared to the current price of 4.63.
DIVERSIFIED HEALTHCARE TRUST (DHC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.37).
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on DHC.
ChartMill assigns a technical rating of 10 / 10 to DHC. When comparing the yearly performance of all stocks, DHC is one of the better performing stocks in the market, outperforming 94.34% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to DHC. DHC may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months DHC reported a non-GAAP Earnings per Share(EPS) of -1.37. The EPS decreased by -22.32% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -7.52% | ||
| ROE | -20.85% | ||
| Debt/Equity | 1.61 |
10 analysts have analysed DHC and the average price target is 4.34 USD. This implies a price decrease of -6.37% is expected in the next year compared to the current price of 4.63.
For the next year, analysts expect an EPS growth of 20.64% and a revenue growth 3.66% for DHC